• @SchmidtGenetics
    link
    English
    -1
    edit-2
    6 months ago

    So they can talk about the relevant commercialization technical bits (the db) and they can’t talk about the part that’s not…? Uhh… what…?

    Is that your argument? Does that make any sense to you…? The part that should be restricted is being talked about freely… and the part that shouldn’t be restricted is…? You’re defending the system that’s backwards. And you want to call me naive and obtuse… okay, defend marketing fluff that you ate up like they were expecting….